Biolipox Interim Report, January - March 2007

- Revenues for the first quarter amounted to SEK 7.8 million (11.1).
- Earnings after tax for the first quarter amounted to SEK -27.6 million (-16.8).
- Earnings per share for the first quarter was SEK -36.81 (-24.96).
- Cash flow for the first quarter was negative and amounted to SEK -21.5 million
(positive:16.9).
- Drug development projects advance according to plan.



Forthcoming financial information
- Interim report, January - June 2007 29 August 2007
- Interim report, January - September 2007 18 October 2007


Biolipox’s interim report 1 January - 31 March 2007, is presented on the following pages.







For further information, please contact:
Torbjörn Bjerke, President & CEO, Tel: +46-70-866 19 90,
e-mail: torbjorn.bjerke@biolipox.com
Peter Hein, VP & CFO, Tel: +46-8-524 831 10, or +46-73-370 73 43,
e-mail: peter.hein@biolipox.com